Consorci Sanitari de l'Anoia

Quick facts

Phase 3 pipeline

• Sedation with midazolam · Anesthesia/Sedation
  Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at the GABA-A receptor, depressing central nervous system activity to produce sedation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Consorci Sanitari de l'Anoia portfolio CI brief
• Consorci Sanitari de l'Anoia pipeline updates RSS